Simon Michel, Ypsomed CEO: “There is a large pool of qualified people in Barcelona”
24 May 2022
Business Investments · Life Sciences
The Swiss medtech company Ypsomed is a world leader in manufacturing insulin pens. Ypsomed has chosen Barcelona to open its first R&D center outside Switzerland and expects to build a workforce of 60 people over the next year.
CEO Simon Michel explains in this interview how, from Barcelona, the company will do everything that involves digitalizing its devices. Finding the best talent pool in Catalonia was a determining factor for the new investment, as well as sharing the same cultural values.
Simon Michel also highlights the support Ypsomed received from Catalonia Trade & Investment to find the right location and to undergo the recruiting process.
Interested in investing in Barcelona - Catalonia?
We are the one-stop shop for international companies looking to establish or expand their operations in Catalonia. Contact us and we will help you grow.
Check out our services.
Business Location Service
Get all the information about industrial buildings, land, business centers, or office spaces in Barcelona-Catalonia.
Access to talent
Access to all sources of available talent for international companies in Barcelona-Catalonia.
International Mobility for Executives
We will guide you through the international mobility process from start to finish.
Related news and success stories.
30 Mar 2023
Automobile Barcelona will promote sustainability with the largest selection of electrified vehicles
30 Mar 2023
Catalonia Industry Suppliers directory has identified over 5,200 industrial and technological suppliers since its launch in 2020
24 Mar 2023
Kerry Group establishes its southern European innovation hub in Barcelona
23 Mar 2023
American multinational Americold invests 13 million euros in expanding its facilities in Barcelona